Benzquinamide
Drug profile
Also known as: benzquinamide HCl, benzquinamide hydrochloride, emeticon, promecon
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Benzquinamide is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1974. DrugCentral lists 7 molecular targets, including PTGS2, ADRA2C and DRD4. Recorded indications include Postoperative nausea and vomiting.
- Approval status: ofm (first approved 1974 by the FDA).
- Molecular targets: PTGS2, ADRA2C, DRD4 and ADRA2B (7 listed in DrugCentral).
- Indications: Postoperative nausea and vomiting.
- Molecular formula: C22H32N2O5; molecular weight 404.51 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Postoperative nausea and vomiting
Mechanism & targets
Molecular targets (7)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Prostaglandin G/H synthase 2 | PTGS2 | inhibitor | IC50 8.32 |
| Alpha-2C adrenergic receptor | ADRA2C | unknown | Ki 6.26 |
| D(4) dopamine receptor | DRD4 | unknown | Ki 6.24 |
| Alpha-2B adrenergic receptor | ADRA2B | unknown | Ki 6.16 |
| Alpha-2A adrenergic receptor | ADRA2A | unknown | Ki 5.87 |
| D(3) dopamine receptor | DRD3 | unknown | Ki 5.45 |
| D(2) dopamine receptor | DRD2 | agonist | Ki 5.40 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1974-03-12 | FDA | — | — |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Benzquinamide is on its molecule page.
| Molecular formula | C22H32N2O5 |
|---|---|
| Molecular weight | 404.51 g/mol |
| CAS number | 63-12-7 |
| InChIKey | JSZILQVIPPROJI-UHFFFAOYSA-N |
| PubChem CID | 2342 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Benzquinamide used for?
DrugCentral lists the following indications for Benzquinamide: Postoperative nausea and vomiting.
How does Benzquinamide work?
Its molecular targets in DrugCentral include PTGS2 (inhibitor), ADRA2C, DRD4 and ADRA2B.
When was Benzquinamide first approved?
Benzquinamide was first approved by the FDA in 1974.
What is the chemical formula of Benzquinamide?
Benzquinamide has the molecular formula C22H32N2O5 and a molecular weight of 404.51 g/mol.
Browse: all drugs starting with B · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 331 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200707 — compound record and bioactivity
- PubChem CID 2342 — chemical identifiers
- DrugBank DB00767 — drug record
- FDA UNII 0475EA27Q3 — substance identity
- DailyMed: FDA labels for Benzquinamide — current prescribing information (label search)
- UniProt P35354 (PTGS2) — target protein
- UniProt P18825 (ADRA2C) — target protein
- UniProt P21917 (DRD4) — target protein
- UniProt P18089 (ADRA2B) — target protein
- UniProt P08913 (ADRA2A) — target protein
- UniProt P35462 (DRD3) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.